Abstract
A comprehensive understanding of endothelial cell lineage specification will advance cardiovascular regenerative medicine. Recent studies found that unique epigenetic signatures preferentially regulate cell identity genes. We thus systematically investigate the epigenetic landscape of endothelial cell lineage and identify MECOM to be the leading candidate as an endothelial cell lineage regulator. Single-cell RNA-Seq analysis verifies that MECOM-positive cells are exclusively enriched in the cell cluster of bona fide endothelial cells derived from induced pluripotent stem cells. Our experiments demonstrate that MECOM depletion impairs human endothelial cell differentiation, functions, and Zebrafish angiogenesis. Through integrative analysis of Hi-C, DNase-Seq, ChIP-Seq, and RNA-Seq data, we find MECOM binds enhancers that form chromatin loops to regulate endothelial cell identity genes. Further, we identify and verify the VEGF signaling pathway to be a key target of MECOM. Our work provides important insights into epigenetic regulation of cell identity and uncovered MECOM as an endothelial cell lineage regulator.
Original language | English (US) |
---|---|
Article number | 2390 |
Journal | Nature communications |
Volume | 14 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2023 |
Funding
This work is supported by grants from NIH/NIGMS (R01GM125632 and R01GM138407 to K.C.) and NIH/NHLBI (R01HL133254 to J.C. and K.C.; R01HL148338 to J.C. and K.C.; 1R01HL132155 to L.F.; and R01HL155632 to L.Z.), and Additional Ventures (Single Ventricle Research Foundation to L.Z.), George and Angelina foundation to L.F., and Cancer Prevention Research Institute of Texas (CPRIT) grants RP150611 and RP170002. Q.C. is supported by U.S. Department of Defense (W81XWH-15-1-0639 and W81XWH-17-1-0357), American Cancer Society (TBE-128382) and NIH/NCI (R01CA208257).
ASJC Scopus subject areas
- General Chemistry
- General Biochemistry, Genetics and Molecular Biology
- General Physics and Astronomy